Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
2126
DELISTED
New Gold Inc
NGD
| $1.38M | ﹤0.01% |
1,539,162
| – | – |
|
|
ECHO
2127
EchoStar
ECHO
$26.6B
| $1.38M | ﹤0.01% |
83,900
-3,500
| -4% | -$65.4K |
|
2128
Viridian Therapeutics
VRDN
$2.52B
| $1.38M | ﹤0.01% |
67,400
+30,700
| +84% | +$552K |
|
2129
W&T Offshore
WTI
$545M
| $1.38M | ﹤0.01% |
235,900
| – | – |
|
2130
Vertex
VERX
$1.98B
| $1.38M | ﹤0.01% |
101,000
+4,900
| +5% | +$62.1K |
|
2131
Castle Biosciences
CSTL
$958M
| $1.38M | ﹤0.01% |
52,900
+2,100
| +4% | +$58.9K |
|
2132
Franklin Covey
FC
$230M
| $1.38M | ﹤0.01% |
30,400
| – | – |
|
|
MAXN
2133
DELISTED
Maxeon Solar Technologies
MAXN
| $1.38M | ﹤0.01% |
580
| – | – |
|
|
DENN
2134
DELISTED
Denny's
DENN
| $1.38M | ﹤0.01% |
146,300
-3,600
| -2% | -$34.5K |
|
2135
Repay Holdings
RPAY
$306M
| $1.38M | ﹤0.01% |
194,883
+2,900
| +2% | +$31.6K |
|
2136
Theravance Biopharma
TBPH
$878M
| $1.37M | ﹤0.01% |
135,342
+4,700
| +4% | +$44K |
|
2137
Great Southern Bancorp
GSBC
$886M
| $1.37M | ﹤0.01% |
24,000
-1,200
| -5% | -$72.4K |
|
|
NAPA
2138
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.37M | ﹤0.01% |
94,900
| – | – |
|
2139
NETGEAR
NTGR
$648M
| $1.37M | ﹤0.01% |
68,200
-1,000
| -1% | -$22.5K |
|
2140
Conduent
CNDT
$243M
| $1.37M | ﹤0.01% |
409,054
+6,500
| +2% | +$27.1K |
|
|
OSG
2141
Octave Specialty Group
OSG
$209M
| $1.36M | ﹤0.01% |
106,800
-2,700
| -2% | -$36K |
|
2142
AMC Global Media
AMCX
$499M
| $1.36M | ﹤0.01% |
67,100
+1,600
| +2% | +$44.1K |
|
2143
Barrett Business Services
BBSI
$775M
| $1.36M | ﹤0.01% |
69,600
-1,600
| -2% | -$32K |
|
|
RXDX
2144
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.36M | ﹤0.01% |
23,000
| – | – |
|
2145
Portillo's
PTLO
$363M
| $1.35M | ﹤0.01% |
68,800
+18,200
| +36% | +$401K |
|
2146
Titan Machinery
TITN
$422M
| $1.35M | ﹤0.01% |
47,900
| – | – |
|
2147
IDEAYA Biosciences
IDYA
$3.56B
| $1.35M | ﹤0.01% |
90,700
+26,900
| +42% | +$349K |
|
|
RAPT
2148
DELISTED
RAPT Therapeutics
RAPT
| $1.35M | ﹤0.01% |
7,025
+75
| +1% | +$14.2K |
|
2149
Central Pacific Financial
CPF
$1.01B
| $1.35M | ﹤0.01% |
65,200
| – | – |
|
2150
Resources Connection
RGP
$145M
| $1.35M | ﹤0.01% |
74,600
+1,800
| +2% | +$36.1K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.